Enjoy Part II of the RESI Recap series authored by OBIO's Klaus Fiebig, VP Strategic Programs
OBIO's own VP Strategic Programs, Klaus Fiebig, shares his impressions and advice garnered from RESI on MaRS last week highlighting some of the trends and sentiments about early stage fundraising.
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches
OBIO has provided feedback to the Ministry of Research Innovation and Science on the the Province's request to recruit Ontario's First Chief Science Officer.
The Ontario Bioscience Innovation Organization Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry
The Ontario Bioscience Innovation Organization Announces New Public Relations & Communications Services Member Benefit
OBIO hosted its Annual Public Meeting with the theme centered on “Bridging the Access to Talent Gap” at Norton Rose Fulbright LLP yesterday. The OBIO Annual Public Meeting provided a platform to highlight OBIO’s accomplishments made in 2016, upcoming initiatives for 2017 and an opportunity to hear from Parliamentary Assistant to the Minister of Economic Development and Growth, Cristina Martins and Members of the OBIO MPP Health Science Caucus, MPP Shafiq Qaadri and MPP Bill Walker, who welcomed networking with over 60 health science industry professionals.
Read the Full Press Release HERE
OBIO is pleased to announce a call for applications for the 2017 OBIO Capital Access Advisory Program (CAAP®).
Christine Charette, SVP Strategic Finance, OBIO offers her insights into the premiere conference for MedTech companies.
Thoughts from OBIO's own VP of Strategic Finance, Christine Charette, summarizing the topics relevant to startups at the 2016 AdvaMed Conference.
For the PDF article click here
Christine Charette, SVP Strategic Finance, OBIO shares her advice on navigating the Health Science Investor in Part 2 of the Combined Conference Insights on RESI Boston & Digital Medicine Connect at BioPharm America September 13,14,15 2016
For the full PDF of the article click here
Christine Charette, SVP Strategic Finance, OBIO offers her perspective on the RESI conference and BioPharm America.
For a PDF of the full article, click here
"The Ontario Bioscience Innovation Organization (OBIO) strongly believes that the supply chain of the future must incorporate a formal approach to creating pathways for the adoption and procurement of innovation, to benefit the people of Ontario from both a health and economic perspective."
2016 has already been a productive year for OBIO as we push forward on our advocacy efforts, expand our Health Science networks and partnerships and continue to provide access to capital for Ontario Health Science companies in order for them to reach the next level.
Gail Garland, CEO
For the full strategic review, click here
The article titled "From Opportunities To ROI – Adopting Innovation In Canada" focusses on the key recommendations of the OBIO report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy.”
Click here for the full article